KCNK3 and atrial fibrillation: Moreover, the unique pharmacology of TASK-1/TASK-5 heterodimers is highly relevant for research and the development of novel drugs targeting atrial fibrillation, obstructive or central sleep apnea, and pulmonary arterial hypertension.